Turkish Validity and Reliability of the Bolus Residue Scale in Acute Stroke
BRS-TR
1 other identifier
observational
40
1 country
1
Brief Summary
This study aims to evaluate the validity and reliability of the Turkish version of the Bolus Residue Scale (BRS) in patients with acute stroke. The study has a methodological, observational, and cross-sectional design. Videofluoroscopic swallowing study (VFSS) recordings will be scored independently by trained raters using the BRS. Psychometric properties including construct validity, criterion validity, inter-rater and intra-rater reliability will be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2026
CompletedFirst Submitted
Initial submission to the registry
February 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedFebruary 27, 2026
February 1, 2026
6 months
February 20, 2026
February 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bolus Residue Scale (BRS)
The Bolus Residue Scale (BRS) Turkish version is a videofluoroscopic swallowing assessment tool used to evaluate the severity of pharyngeal residue following swallowing. The scale consists of six ordinal levels, ranging from Grade 1 (no residue) to Grade 6 (severe residue) based on the presence and extent of bolus residue in the pharynx. Higher scores indicate greater pharyngeal residue severity and poorer swallowing efficiency.
Baseline (during videofluoroscopic swallowing study assessment)
Secondary Outcomes (3)
Swallowing Safety Assessed by the Penetration-Aspiration Scale
Baseline (during videofluoroscopic swallowing study assessment)
Pharyngeal Residue Assessed by the Yale Residue Scale
Baseline (during videofluoroscopic swallowing study assessment)
Functional Oral Intake Assessment
Baseline (during videofluoroscopic swallowing study assessment)
Study Arms (1)
Acute Stroke Patients
This cohort consists of patients with acute stroke who underwent videofluoroscopic swallowing study (VFSS) as part of routine clinical evaluation. Swallowing function was assessed using the Bolus Residue Scale (BRS) for the purpose of validity and reliability analysis. No intervention was applied, and no changes were made to standard clinical care.
Interventions
This study does not involve any therapeutic, behavioral, or procedural intervention. All assessments were performed as part of routine clinical care, and no changes were made to standard treatment or clinical management.
Eligibility Criteria
The study population consisted of adult patients with acute stroke who were referred for videofluoroscopic swallowing study (VFSS) as part of routine clinical care. All participants underwent swallowing assessment using standardized residue and swallowing scales. No intervention was applied, and all evaluations were conducted within standard clinical practice.
You may qualify if:
- Diagnosis of acute stroke confirmed by neurological and radiological evaluation
- Age 18 years and older
- Undergoing videofluoroscopic swallowing study (VFSS) as part of routine clinical assessment
- Ability to participate in swallowing assessment procedures
- Provision of written informed consent by the patient or a legal representative
You may not qualify if:
- History of head and neck cancer or head and neck surgery
- Pre-existing neurological diseases affecting swallowing (e.g., Parkinson's disease, amyotrophic lateral sclerosis)
- Structural abnormalities of the upper aerodigestive tract
- Severe cognitive impairment preventing cooperation with assessment procedures
- Incomplete or poor-quality VFSS recordings unsuitable for analysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istanbul Arel Universitylead
- Hacettepe Universitycollaborator
- Istinye Universitycollaborator
- Atlas Universitycollaborator
Study Sites (1)
Istanbul Arel University
Istanbul, Zeytinburnu, 34015, Turkey (Türkiye)
Related Publications (2)
Soyer T, Arslan SS, Pisiren B, Boybeyi O, Yalcin E, Demir N. The Role of Bolus Residue and Its Relation with Respiratory Problems in Children with Esophageal Atresia. Dysphagia. 2023 Dec;38(6):1546-1550. doi: 10.1007/s00455-023-10582-1. Epub 2023 May 3.
PMID: 37138140BACKGROUNDRommel N, Borgers C, Van Beckevoort D, Goeleven A, Dejaeger E, Omari TI. Bolus Residue Scale: An Easy-to-Use and Reliable Videofluoroscopic Analysis Tool to Score Bolus Residue in Patients with Dysphagia. Int J Otolaryngol. 2015;2015:780197. doi: 10.1155/2015/780197. Epub 2015 Nov 12.
PMID: 26640491RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
February 20, 2026
First Posted
February 27, 2026
Study Start
August 1, 2025
Primary Completion
January 15, 2026
Study Completion
February 20, 2026
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to ethical restrictions and data protection regulations. The data are collected as part of routine clinical care and include sensitive health information, and no consent for public data sharing has been obtained from participants.